117 institutions reported holding $1.11B of AKTIS ONCOLOGY (AKTS) in SEC 13F filings for 2026-06-30. Largest institutional holders: MPM BIOIMPACT LLC ($155.9M), EcoR1 Capital, LLC ($155.5M), Blue Owl Capital Holdings LP ($99.0M), BlackRock, Inc. ($73.4M), T. Rowe Price Investment Management, Inc. ($66.1M). Source: SEC Form 13F.
来源:SEC 13F 申报文件 · 截至 2026-06-30